Literature DB >> 2857972

Tamoxifen and arterial thrombosis.

R Dahan, M Espie, L Mignot, D Houlbert, B Chanu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2857972     DOI： 10.1016/s0140-6736(85)92173-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Life threatening interaction between tamoxifen and warfarin.

Authors:  R Lodwick; B McConkey; A M Brown
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-31

Review 2.  Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  M M Buckley; K L Goa
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

Review 3.  Tamoxifen as adjuvant therapy in breast cancer. Current status.

Authors:  P N Plowman
Journal:  Drugs       Date:  1993-11       Impact factor: 9.546

4.  Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee.

Authors:  C C McDonald; H J Stewart
Journal:  BMJ       Date:  1991-08-24

Review 5.  A risk-benefit assessment of tamoxifen therapy.

Authors:  W H Catherino; V C Jordan
Journal:  Drug Saf       Date:  1993-05       Impact factor: 5.606

6.  Haemostatic changes and thromboembolic risk during tamoxifen therapy in normal women.

Authors:  A L Jones; T J Powles; J G Treleaven; J F Burman; M C Nicolson; H I Chung; S E Ashley
Journal:  Br J Cancer       Date:  1992-10       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.